University of Louisville homepage
All experts
All experts

Donghoon Chung

Professor

School of Medicine

Orcid identifier0000-0003-2626-172X
  • Professor
    School of Medicine
  • 502-852-5522 (Work)
  • University of Louisville, Microbiology and Immunology, 505 Hancock Street CTRB Rm 617, Louisville, KY, 40202, United States

SPONSORED PROJECTS

My lab is particularly interested in alphaviruses and flaviviruses. We also study neurological impacts from neurotropic viruses.

SPONSORED PROJECTS

  • Showing page 1 out of 1
Showing page 1, sponsored projects 1 to 24 of 24
GRANT
Optimization of a novel and effective antiviral agent targeting Zika NS4B
National Institutes of Health_NIH6 Oct 2026 - 31 Dec 2031
MORELEARN MORE
GRANT
Foreign Subaward Component: Optimization of a novel and effective antiviral agent targeting Zika NS4B
National Institutes of Health_NIH6 May 2026 - 31 Dec 2031
MORELEARN MORE
GRANT
Development of novel antivirals for arthritogenic alphaviruses
National Institute of Allergy and Infectious Diseases24 Sep 2025 - 31 Aug 2030
People funded by this grant: CHUNG D, BANNISTER TD, LUO D
MORELEARN MORE
GRANT
250455|Development of novel antivirals for arthritogenic alphaviruses
National Institutes of Health_NIH1 Jul 2025 - 30 Jun 2030
MORELEARN MORE
GRANT
240290|Neuroinvasion and Neurovirulence with Toxicology, Biodistribution and Shedding
Medigen Inc_MEDIGEN1 Jan 2024
MORELEARN MORE
GRANT
Neuroinvasion and neurovirulence with toxicology, biodistribution and shedding
Medigen1 Jan 2024 - 31 Dec 2025
GRANT
230714|BSL3 PWD Core - UofL RBL Operations, Workforce Development and Pandemic Preparedness Research
National Institutes of Health_NIH1 Jan 2023
MORELEARN MORE
GRANT
230714|BSL3 PWD Core - UofL RBL Operations, Workforce Development and Pandemic Preparedness Research
National Institutes of Health_NIH1 Jan 2023 - 31 Dec 2028
MORELEARN MORE
GRANT
220959|Mechanism of action and resistance to NHC by Chikungunya virus
Merck and Company Inc_MERCKCO11 Sep 2022
MORELEARN MORE
GRANT
Mechanism of action and resistance to NHC by Chikungunya virus
Merck & Co., Inc.7 Jul 2022 - 31 Dec 2025
GRANT
Midwest AViDD Center
National Institute of Allergy and Infectious Diseases16 May 2022 - 30 Apr 2025
People funded by this grant: HARRIS RS, LI F, SCAMPAVIA LD, BANNISTER TD, AMARO RE
MORELEARN MORE
GRANT
220958S1|Noninvasive in vivo imaging of lung inflammation induced by SARS-CoV2 in small animal models using ImmunoPET
Univ of Minnesota_UMINN9 Jan 2022
MORELEARN MORE
GRANT
220958|MidWest AViDD Center-Project 5
Univ of Minnesota_UMINN1 Jan 2022
MORELEARN MORE
GRANT
220958|MidWest AViDD Center-Project 5
Univ of Minnesota_UMINN1 Jan 2022 - 31 Dec 2026
MORELEARN MORE
GRANT
200215|Genetic Rearrangement of CHIKV iDNA Vaccine
Medigen Inc_MEDIGEN4 Mar 2020
MORELEARN MORE
GRANT
201186|Antiviral Mechanism of Brequinar
Clear Creek Bio Inc_CCBI9 Jan 2020
MORELEARN MORE
GRANT
180961|Center of Excellence for Encephalitic Alphavirus Therapeutics
Univ of Tennessee_UT3 Jun 2019
MORELEARN MORE
GRANT
180961|Center of Excellence for Encephalitic Alphavirus Therapeutics - In Vitro Evaluation and Characterization of Novel Lead Therapeutic Candidates for Encephalitic Alphavirus Treatment.
Univ of Tennessee_UT3 Jun 2019
MORELEARN MORE
GRANT
180961|Center of Excellence for Encephalitic Alphavirus Therapeutics - In vitro evaluation and characterization of novel lead therarpeutic candidates for encephalitic alphavirus treatment
Univ of Tennessee_UT3 Jun 2019
MORELEARN MORE
GRANT
180961|In vitro evaluation and characterization of novel lead therarpeutic candidates for encephalitic alphavirus treatment
Univ of Tennessee_UT3 Jun 2019
MORELEARN MORE
GRANT
Center of Excellence for Encephalitic Alphavirus Therapeutics
National Institute of Allergy and Infectious Diseases6 Mar 2019 - 28 Feb 2026
People funded by this grant: JONSSON CB, GOLDEN JE, CHUNG D
MORELEARN MORE
GRANT
Lead Optimization of ML336, a Potent VEEV Inhibitor
National Institute of Allergy and Infectious Diseases1 May 2015 - 30 Apr 2021
People funded by this grant: CHUNG D, GOLDEN JE, JONSSON CB
MORELEARN MORE
GRANT
150382|Lead Optimization of ML336, a Potent VEEV Inhibitor
National Institutes of Health_NIH5 Jan 2015 - 31 Dec 2021
MORELEARN MORE
GRANT
A Cell-Based HTS to Discover Molecules that Inhibit VEEV Replication
National Institute of Mental Health1 Jan 2011 - 30 Apr 2013
People funded by this grant: CHUNG D
MORELEARN MORE